The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.
Open accessAbstract
The effects of plasminogen activator inhibitor-1 (PAI-1) gene inactivation on hemostasis, thrombosis and thrombolysis were studied in homozygous PAI-1-deficient (PAI-1-/-) mice, generated by homologous recombination in D3 embryonic stem cells. Diluted (10-fold) whole blood clots from PAI-1-/- and from PAI-1 wild type (PAI-1+/+) mice underwent limited but significantly different (P < 0.001) spontaneous lysis within 3 h (6 +/- 1 vs 3 +/- 1%, respectively). A 25-microliters 125I-fibrin-labeled normal murine plasma clot, injected into a jugular vein, was lysed for 47 +/- 5, 66 +/- 3, and 87 +/- 7% within 8 h in PAI-1+/+, heterozygous PAI-1-deficient (PAI-1+/-), and PAI-1-/- mice, respectively (P = 0.002 for PAI-1+/+ vs PAI-1-/- mice). Corresponding values after pretreatment with 0.5 mg/kg endotoxin in PAI-1+/+ and PAI-1-/- mice, were 35 +/- 5 and 91 +/- 3% within 4 h, respectively (P < 0.001). 11 out of 26 PAI-1+/+ but only 1 out of 25 PAI-1-/- mice developed venous thrombosis (P = 0.004) within 6 d after injection of 10 or 50 micrograms endotoxin in the footpad. Spontaneous bleeding or delayed rebleeding could not be documented in PAI-1-/- mice after partial amputation of the tail or of the caecum. Thus, disruption of the PAI-1 gene in mice appears to induce a mild hyperfibrinolytic state and a greater resistance to venous thrombosis but not to impair hemostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Plasminogen activator inhibitors
Sprengers, E., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 1,009
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., & Loskutoff, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6998 · Cited by 543
Sawdey, M. S., & Loskutoff, D. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115440 · Cited by 410
Colucci, M., Paramo, J. A., & Collen, D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111777 · Cited by 390
Self-citationCarmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., & Mulligan, R. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116892 · Cited by 345
Self-citationNilsson, I. M., Ljungnér, H., & Tengborn, L. (1985) · BMJ · doi:10.1136/bmj.290.6480.1453 · Cited by 336
Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
Paramo, J. A., Colucci, M., Collen, D., & van de Werf, F. (1985) · BMJ · doi:10.1136/bmj.291.6495.573 · Cited by 302
Self-citationComplete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation
Fay, W. P., Shapiro, A. D., Shih, J. L., Schleef, R. R., & Ginsburg, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212103272406 · Cited by 271
Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene
Erickson, L. A., Fici, G. J., Lund, J. E., Boyle, T. P., Polites, H. G., & Marotti, K. R. (1990) · Nature · doi:10.1038/346074a0 · Cited by 267
Lupu, F., Bergonzelli, G. E., Heim, D. A., Cousin, E., Genton, C. Y., Bachmann, F., & Kruithof, E. K. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1090 · Cited by 257
A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)
Vermylen, C., De Vreker, R. A., & Verstraete, M. (1963) · Clinica Chimica Acta · doi:10.1016/0009-8981(63)90080-9 · Cited by 256
Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef, R. R., Higgins, D. L., Pillemer, E., & Levitt, L. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114076 · Cited by 210
Aznar, J., Estelles, A., Tormo, G., Sapena, P., Tormo, V, Blanch, S., & Espana, F. (1988) · Heart · doi:10.1136/hrt.59.5.535 · Cited by 188
Glomerular matrix accumulation is linked to inhibition of the plasmin protease system
Tomooka, S., Border, W. A., Marshall, B. C., & Noble, N. A. (1992) · Kidney International · doi:10.1038/ki.1992.442 · Cited by 186
Quax, P. H. A., van den Hoogen, C. M., Verheijen, J. H., Padró, T., Zeheb, R., GELEHRTER, T. D., van Berkel, T. J. C., Kuiper, J., & Emeis, J. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55433-8 · Cited by 143
Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide.
Heremans, H., Dijkmans, R., Sobis, H., Vandekerckhove, F., & Billiau, A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.12.4175 · Cited by 138
Keeton, M., Eguchi, Y., Sawdey, M., Ahn, C., & Loskutoff, D. J. (1993) · PubMed · Cited by 102
Plasminogen activator inhibitors
Schneiderman, J., & Loskutoff, D. J. (1991) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(91)90001-u · Cited by 87
On the role of coagulation and fibrinolysis in atherosclerosis
Juhan-Vague, I., & Collen, D. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90092-5 · Cited by 67
Self-citation
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Self-citationThe plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Eriksson, P., Kallin, B., van 't Hooft, F. M., Båvenholm, P., & Hamsten, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1851 · Cited by 739
Metadata
- Authors
- Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C., & Collen, D.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-12-01
- Volume
- 92
- Issue
- 6
- Pages
- 2756-2760
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2032102036
- Cited by
- 388
- References
- 21
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.